Basket - Other
ZOLAR
An open-label, Phase 1 study to assess safety, tolerability, dosimetry, pharmacokinetics and imaging properties of 89Zr-olaratumab (89ZrTLX300-CDx) in participants with PDGFR alpha positive solid tumours and soft tissue sarcoma
Trial overview
Clinical Area
Theranostics
Disease
Basket
Disease site
Basket
Study Phase
I
Trial Identifiers
Registration number: NCT06537596
GenesisCare Location(s)
Principal Investigator(s)